CPC A61K 31/7125 (2013.01) [A61K 31/713 (2013.01); A61P 1/04 (2018.01)] | 7 Claims |
1. A pharmaceutical composition for preventing or treating inflammatory bowel disease, comprising an intestinal organoid and a TNFα inhibitor,
wherein the inflammatory bowel disease is one or more selected from the group consisting of ischemic colitis, intestinal Behcet's disease, Crohn's disease, ulcerative colitis and ulcerative proctitis.
|